CASP3 and Alzheimer disease: We measured MCL-1 protein expression in cLNs to examine the systemic effects of orally administered sesamin, finding that it downregulated the elevated levels of phosphorylated MCL-1 in the AD model while upregulating those of cleaved caspase 3 and 8 (Fig. 10B).